“…Specifically, our primary objective was to determine whether, relative to non-infected controls, individuals with HCV exhibit differences in brain activation during a DDT. Previous neuroimaging studies comparing untreated adults with HCV to non-infected controls have found a variety of HCV associated changes using various methods (electroencephalogram (EEG) (Weissenborn, Krause et al 2004); magnetic resonance spectroscopy (MRS) (Forton, Allsop et al 2001, Taylor, Letendre et al 2004, Weissenborn, Krause et al 2004, McAndrews, Farcnik et al 2005, Bladowska, Zimny et al 2013, Thames, Castellon et al 2015); multimodal MRI or diffusion tensor imaging (DTI) (Bladowska, Zimny et al 2013, Thames, Castellon et al 2015, Kharabian Masouleh, Herzig et al 2017, Kumar, Deep et al 2017); perfusion-weighted MRI (Bladowska, Zimny et al 2013, Bladowska, Knysz et al 2014); positron emission tomography (PET) (Grover, Pavese et al 2012, Pflugrad, Meyer et al 2016)). Collectively, findings could be interpreted to suggest that HCV causes or is associated with central nervous system (CNS) inflammation, damage, and/or neurodegeneration.…”